lastminute.com N.V. (0QT0)
London Exchange · UK · prices in GBP · close of 22 Oct 2026
Key indicators
| Last close | GBP 9.460 |
|---|---|
| 52-week range | 9.000 – 15.750 |
| Return, 1 month / 3 months | −3.5% / −28.1% |
| Return, 1 year / 3 years | −35.4% / −55.6% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 39.6% |
| Worst drawdown (1 year) | -42.8% |
| Average daily value traded | 0.02M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
lastminute.com is an online travel company that helps people book trips and leisure activities through its websites. It offers flights, hotel stays, package holidays, and tickets for shows and events, serving leisure travellers who want to arrange trips at short notice or compare options online. The company is based in Amsterdam in the Netherlands and focuses on customers in European markets, combining travel booking with inspiration for things to do at the destination.
The shares are listed on the London Exchange in UK under the code 0QT0, and the price on this page is in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
lastminute.com N.V. (0QT0) trades on the London Exchange in UK. It last closed at GBP 9.460 on 22 October 2026.
Its price-based Market X-Ray is 20 out of 100 (a weak price profile), ranking 3,448 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 35.4% and over the last three months it fell 28.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 15 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -23.6% | ||
| From 52-week high | -39.9% | ||
| Momentum | 12 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -28.1% | ||
| 6-month return | -22.1% | ||
| 12-month return, skipping the last month | -33.1% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -42.8% | ||
| Liquidity | 15 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.4% |
|---|---|
| 1 month | −3.5% |
| 3 months | −28.1% |
| 6 months | −22.1% |
| 1 year | −35.4% |
| 3 years | −55.6% |
| 5 years | −78.2% |
Signals
| 50-day / 200-day average | 10.407 / 12.378 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.236 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jul 2026 | GBX 0.0038 |
| 2 Jul 2025 | GBX 0.0038 |
| 26 Jun 2024 | GBX 0.0037 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.